Morepen Board Proposed Dividend After 23 Years Scores Highest PAT of ₹118 Crore in FY25

“Thank You” House Help: “Thank You” Dr. Morepen

Morepen Laboratories plans to add 1,000 medical representatives

Morepen to Launch Resmetirom- a New Drug for Fatty Liver

Morepen Set For Bold Expansion: To Add 1000 Medical Representatives

Morepen secures Loratadine approval for export to China

Morepen launches Empamore for diabetes care with affordable treatment

New Launch: Empamore! Trusted, high-quality diabetes treatment—now at 90% lower cost!

Dr. Morepen Sync Mobile App: A Republic Day Gift to Transform Health Monitoring in India